Initiatives Hub
ACRO’s initiatives bring together subject matter experts from each of ACRO’s member companies to work collaboratively on the topics most impacting clinical research today. Read more about ACRO’s top initiatives, including AI/ML in drug development, risk-based quality management, and diversity, equity, and inclusion in clinical trials:
Artificial Intelligence & Machine Learning
ACRO’s AI/ML Committee brings together member company subject matter experts engaged in the development and use of AI/ML tools in the design, conduct, oversight, and analysis of clinical trials.
Diversity & Inclusion in Clinical Trials
ACRO’s Diversity and Inclusion in Clinical Trials Committee was formed in 2020 as a part of ACRO’s ongoing efforts to work towards advancing diversity, equity, and inclusion in the clinical research ecosystem.
Risk-Based Quality Management
Risk-based monitoring is an adaptive approach that directs monitoring focus and activities to the evolving areas of greatest need which have the most potential to impact patient safety and data quality.